Working Note: Dl Chemical Group

Knowledge Snapshot

This file is internal issuer coverage memory for handoff to a new research agent. It records objective context and confirmed facts; detailed numerical series should remain in data/dl_chemical_group_financial_extract_20260518.json.

Last updated: 2026-06-12

Issuer Overview

• DL Chemical group is the chemical and specialty materials business under Korea's DL Holdings.
• The relevant business perimeter includes DL Chemical Co., Ltd. on a separate basis, Kraton Corporation, Cariflex, DL FnC, D-REX Polymer and related subsidiaries / JVs. DL Holdings consolidated figures include non-chemical businesses and must not be treated as the direct repayment source for chemical creditors without legal-entity confirmation.
• The KRA market reference comes from former Kraton Corporation. Kraton was acquired by DL Chemical in 2022 and now operates within the DL Chemical group.
• The group combines Korean PE, PB and EPO operations; Kraton's SBC and Pine Chemical businesses; Cariflex's synthetic rubber and latex business; BOPP film; APAO; and related specialty / petrochemical affiliates.

Core Credit View

• DL Chemical group's unsecured credit should be analysed as a post-acquisition chemicals credit with specialty-product support but significant earnings, leverage, foreign-exchange, interest-rate and structural complexity.
• PB, Cariflex and Kraton provide better product positioning than a pure commodity petrochemical profile, but the group remains exposed to raw materials, spreads, volumes, utilisation, seasonality and integration burden.
• 2025 showed material earnings pressure at DL Holdings consolidated and DL Chemical consolidated levels, while 1Q 2026 showed a rebound in DL Chemical and Kraton operating profit. The 1Q rebound should be treated as an initial recovery signal, not a completed credit improvement.
• Kraton's KDB-guaranteed USD global bonds are a separate bond-level credit case. Their credit depends heavily on the legal effectiveness, scope and claim mechanics of the KDB guarantee and KDB's own credit quality, not only on DL Chemical group standalone fundamentals.

Business and Franchise View

• DL Chemical separate has positions in PE, PB and EPO. The official website highlights a strong PB position and PB open-market leadership.
• Kraton provides global specialty polymers and Pine Chemical exposure across applications such as adhesives, coatings, consumer goods, medical, packaging, automotive, paving, tires and oilfield chemicals.
• Cariflex is a high-margin specialty business focused on synthetic rubber and latex for medical applications, but its scale is much smaller than Kraton's and cannot by itself absorb group-wide chemical volatility.
• DL FnC, D-REX Polymer, NOTARK and related JVs broaden the product portfolio, but their individual cash-flow and profit contribution were not sufficiently disclosed in the current source base.
• YNCC and PolyMirae are relevant for business linkage and raw-material / product-chain context, but should be handled carefully as affiliates rather than direct repayment sources.

Capital Structure and Structural Points

• DL Holdings is the listed holding-company context for the group and owns a controlling stake in DL Chemical. Parent-level support, banking relationships and capital actions matter, but legal-entity access to cash must be verified.
• Kraton's USD1.0bn three-year global bonds issued in 2024 carry a KDB credit guarantee according to Kraton's press release and Moody's public headline. The full offering circular and guarantee deed have not been reviewed.
• Unsecured DL Chemical group credit, DL Holdings parent credit, Kraton standalone credit, domestic Korean bonds and KDB-guaranteed offshore bonds must be separated security by security.
• Post-Kraton acquisition goodwill, intangible assets, non-current liabilities, foreign-currency exposure and restructuring / impairment risk are structurally important.

Liquidity and Funding View

• DL Holdings consolidated cash is supportive as background, but should not be attributed directly to DL Chemical, Kraton, Cariflex or any individual bondholder without confirming legal-entity cash and intercompany arrangements.
• DL Holdings' 1Q 2026 materials showed heavy consolidated net interest-bearing debt. This keeps unsecured credit assessment dependent on cash flow, refinancing access and maturity profile.
• Confirmed source materials do not yet provide a complete DL Chemical group standalone view of operating cash flow, FCF, gross debt, short-term debt, legal-entity cash, foreign-currency debt, hedging or committed lines.
• KDB-guaranteed bonds may have strong bond-level liquidity / credit support if the guarantee is confirmed as unconditional, irrevocable and timely payment, but that cannot be assumed without reading the legal documentation.

Credit Strengths

• Specialty product base in PB, Kraton's polymers / Pine Chemical and Cariflex's medical synthetic rubber / latex.
• Geographic and product diversification across Korea, the US, Europe, Singapore, Brazil and other markets.
• Parent-group context under DL Holdings and access to banking / capital-market relationships.
• Kraton's 1Q 2026 operating-profit rebound from the 4Q 2025 loss.
• KDB guarantee is potentially a very strong bond-level support for the guaranteed Kraton notes, subject to legal-document confirmation.

Credit Weaknesses

• Kraton is large in revenue terms and its 2025 weakness / 4Q loss materially constrained the group credit view.
• DL Chemical consolidated operating profit fell sharply in 2025, and DL Holdings consolidated bottom-line profit turned negative.
• Operating cash flow, FCF, legal-entity debt, maturity profile and undrawn lines for DL Chemical group remain unconfirmed.
• Raw-material, spread, volume, utilisation, FX and interest-rate risks can move together.
• Cariflex is profitable but too small to offset group-wide stress alone.
• Structural complexity creates risk of overestimating recovery sources or parent support.

Rating Watchpoints

• For Kraton guaranteed bonds, verify KDB's rating, guarantee wording, claim process, ranking, cross-default and change-of-control language.
• Moody's public headline assigned Aa2 to Kraton's proposed KDB-guaranteed notes, but the full Moody's report was not accessed.
• Public headlines on Kraton standalone credit indicated a much weaker standalone profile than the guaranteed notes; do not mix those ratings.
• Latest domestic rating reports for DL Chemical, DL Holdings and related domestic bonds were not obtained.

Recurring Analytical Cautions

• Do not confuse KRA / Kraton issuer exposure with DL Chemical group unsecured credit.
• Do not use the KDB-guaranteed bond rating as a proxy for DL Chemical group standalone credit.
• Do not treat DL Holdings consolidated cash and operating profit as automatically accessible to Kraton or DL Chemical creditors.
• Label source status carefully: some 2025 segment data came from mirrors or extracts, while 1Q 2026 was later confirmed through official DL Holdings IR materials and DART preliminary disclosure.
• Treat 1Q 2026 as a rebound from a weak 4Q 2025, not as proof of structural normalisation.
• Keep Cariflex's profitability in perspective because its scale is small relative to Kraton.

Reliable Core Sources

• DL Chemical official website for profile, product and group structure.
• DL Holdings official IR Data page and Financial Information page.
• DART / KRX DL Holdings disclosures for regulatory filings and preliminary performance.
• Kraton official newsroom for acquisition completion, KDB-guaranteed bond issuance and 2026 price-increase releases.
• Moody's public headline via ResearchPool for the KDB-guaranteed note rating route.
• data/dl_chemical_group_financial_extract_20260518.json for structured extracted metrics.

Issuer Notes

This file is internal issuer coverage memory for research and writing judgment. It is not a change log. Objective facts and detailed numerical data should remain in knowledge_snapshot.md and data/dl_chemical_group_financial_extract_20260518.json.

Last updated: 2026-06-12

Ongoing Follow-Up Items

• Confirm whether Kraton's 1Q 2026 operating-profit rebound continues in 2Q and later periods.
• Track whether Kraton's 2026 price increases for SBC, CTO refinery products / derivatives, and polymer products translate into sustained spread improvement without volume loss.
• Monitor DL Chemical separate PB / PE margins, raw-material lag effects, production volumes and any renewed 4Q-style weakness.
• Check whether Cariflex's 1Q 2026 customer inventory adjustment was temporary, and monitor medical IR latex demand, customer concentration and utilisation at the Singapore plant.
• Extract DL Chemical group standalone operating cash flow, FCF, gross debt, short-term debt, interest expense, maturity profile, legal-entity cash, foreign-currency debt, hedging and committed lines from official filings.
• Obtain the Kraton USD1.0bn KDB-guaranteed note offering circular, guarantee deed, pricing supplement and covenant package.
• Check latest original domestic rating reports, bond-management agreements and guarantee / collateral terms for DL Chemical and DL Holdings domestic bonds.
• Monitor capex, production rationalisation, Kraton / Cariflex restructuring, Berre France production changes and any additional impairment.

Unresolved Issues and Items to Check Next Time

• Full legal documentation for the KDB guarantee remains unconfirmed, including whether the guarantee is unconditional, irrevocable, pari passu and timely payment.
• Kraton standalone cash flow, borrowings, working capital, capex, liquidity and segment-level profitability remain insufficiently verified.
• DL Chemical group full-year 2025 cash flow, FCF, debt and maturity schedule remain unconfirmed.
• Legal-entity cash and foreign-currency cash across DL Holdings, DL Chemical, Kraton and Cariflex remain unconfirmed.
• Unused committed bank lines and refinancing backstops remain unconfirmed.
• Domestic bond covenants, cross-default, guarantee scope and financial-maintenance clauses need original-document verification.
• Live bond prices, KDB-bond spread comparison, OAS / Z-spreads and trading liquidity have not been assessed.

Analytical Cautions

• Keep three layers separate: DL Chemical group unsecured credit, Kraton standalone issuer credit, and Kraton KDB-guaranteed bond credit.
• Parent consolidated figures can show support capacity but are not automatically creditor-accessible cash.
• The 1Q 2026 rebound reduces near-term downside pressure but should not raise the credit view until sustained Kraton profitability and cash-flow recovery are confirmed.
• Cariflex is a high-quality earnings source, but its small scale limits its ability to offset Kraton weakness.
• Chemical earnings can deteriorate through simultaneous raw-material, FX, interest-rate, volume, spread and impairment pressure.
• Specialty chemical positioning is a support, not immunity from cyclical or post-acquisition leverage risk.
• Public headlines and mirrored company materials should be replaced by official filings or direct company PDFs when doing a detailed refresh.

Report Wording Cautions

• For KDB-guaranteed notes, write "bond-level credit depends on the KDB guarantee and KDB credit" rather than implying that Kraton or DL Chemical standalone credit is Aa-level.
• For DL Chemical group, avoid wording that treats it as a stable investment-grade chemical issuer until cash-flow, debt and Kraton normalisation are verified.
• Describe 1Q 2026 figures as preliminary / investor-material figures before external auditor review unless a later audited or reviewed filing is used.
• Use "DL Chemical separate", "DL Chemical consolidated", "DL Holdings consolidated", "Kraton issuer scope" and "KDB-guaranteed notes" consistently.
• Do not use KRA as if it were the legal issuer for every DL Chemical-related bond exposure.

Follow-Up on Management Strategy, Investment Plans, and Financial Policy

• Monitor parent support from DL Holdings, including capital injections, intercompany loans, guarantees, dividends and banking relationships.
• Track Kraton production rationalisation, price actions, restructuring and potential impairment reversal / additional impairment.
• Monitor Cariflex expansion investment and Singapore plant utilisation.
• Watch DL Chemical's shift toward higher-value-added products such as PB, APAO and specialty materials, while checking capex and FCF burden.
• Check whether refinancing strategy changes after the 2024 KDB-guaranteed bond issuance.

Items to Check for Ratings and Bond Investors

• KDB rating and outlook, plus Korean policy-bank support assumptions.
• Moody's full report for the Kraton KDB-guaranteed notes, if accessible.
• Kraton standalone rating actions and triggers.
• Domestic issuer / issue ratings for DL Chemical and DL Holdings.
• Offering circular, guarantee deed, claim mechanics, ranking, cross-default, change of control, negative pledge, events of default, governing law and tax for each bond.
• Spread comparison of the guaranteed Kraton notes against KDB's own bonds and similarly guaranteed Korean policy-bank instruments.